Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

由 Pinter, Matthias, Sieghart, Wolfgang
發表在 Memo (2018)

Response to the Letter to the Editor Concerning the Publication “Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresec...

由 Scheiner, Bernhard, Pinter, Matthias
發表在 Liver Cancer (2020)

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

由 Pinter, Matthias, Jain, Rakesh K.
發表在 Sci Transl Med (2017)

Review article: systemic treatment of hepatocellular carcinoma

由 Pinter, Matthias, Peck‐Radosavljevic, Markus
發表在 Aliment Pharmacol Ther (2018)

Reply to the Letter to the Editor Entitled “Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?”

由 Scheiner, Bernhard, Kirstein, Martha M., Pinter, Matthias
發表在 Liver Cancer (2020)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

由 Pinter, Matthias, Scheiner, Bernhard, Peck-Radosavljevic, Markus
發表在 Gut (2021)

Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events

由 Pinter, Matthias, Kwanten, Wilhelmus J., Jain, Rakesh K.
發表在 Clin Cancer Res (2018)

The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma A Review

由 Pinter, Matthias, Jain, Rakesh K., Duda, Dan G.
發表在 JAMA Oncol (2021)

Cancer and liver cirrhosis: implications on prognosis and management

由 Pinter, Matthias, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
發表在 ESMO Open (2016)

The impact of thyroid hormones on patients with hepatocellular carcinoma

由 Pinter, Matthias, Haupt, Lukas, Hucke, Florian, Bota, Simona, Bucsics, Theresa, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
發表在 PLoS One (2017)

Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives

由 Iwanejko, Jakub, Samadaei, Mahzeiar, Pinter, Matthias, Senfter, Daniel, Madlener, Sibylle, Kochel, Andrzej, Rohr-Udilova, Nataliya, Wojaczyńska, Elżbieta
發表在 Materials (Basel) (2021)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma

由 Meischl, Tobias, Rasoul‐Rockenschaub, Susanne, Győri, Georg, Scheiner, Bernhard, Trauner, Michael, Soliman, Thomas, Berlakovich, Gabriela, Pinter, Matthias
發表在 United European Gastroenterol J (2021)

Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma

由 Pinter, Matthias, Sieghart, Wolfgang, Schmid, Monika, Dauser, Bernhard, Prager, Gerald, Dienes, Hans Peter, Trauner, Michael, Peck-Radosavljevic, Markus
出版 2013

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation

由 Meischl, Tobias, Rasoul-Rockenschaub, Susanne, Györi, Georg, Sieghart, Wolfgang, Reiberger, Thomas, Trauner, Michael, Soliman, Thomas, Berlakovich, Gabriela, Pinter, Matthias
發表在 PLoS One (2019)

Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton

由 Samadaei, Mahzeiar, Pinter, Matthias, Senfter, Daniel, Madlener, Sibylle, Rohr-Udilova, Nataliya, Iwan, Dominika, Kamińska, Karolina, Wojaczyńska, Elżbieta, Wojaczyński, Jacek, Kochel, Andrzej
發表在 Molecules (2020)

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib

由 Rohr-Udilova, Nataliya, Klinglmüller, Florian, Seif, Martha, Hayden, Hubert, Bilban, Martin, Pinter, Matthias, Stolze, Klaus, Sieghart, Wolfgang, Peck-Radosavljevic, Markus, Trauner, Michael
發表在 Oncotarget (2017)

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib

由 Pomej, Katharina, Scheiner, Bernhard, Park, Dabin, Bauer, David, Balcar, Lorenz, Meischl, Tobias, Mandorfer, Mattias, Reiberger, Thomas, Müller, Christian, Trauner, Michael, Pinter, Matthias
發表在 Cancers (Basel) (2020)

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice

由 Kortüm, Benedikt, Campregher, Christoph, Lang, Michaela, Khare, Vineeta, Pinter, Matthias, Evstatiev, Rayko, Schmid, Gerald, Mittlböck, Martina, Scharl, Theresa, Kucherlapati, Melanie H, Edelmann, Winfried, Gasche, Christoph
發表在 Gut (2015)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab

由 Li, Shuren, Peck-Radosavljevic, Markus, Ubl, Philipp, Wadsak, Wolfgang, Mitterhauser, Markus, Rainer, Eva, Pinter, Matthias, Wang, Hao, Nanoff, Christian, Kaczirek, Klaus, Haug, Alexander, Hacker, Marcus
發表在 Eur J Nucl Med Mol Imaging (2017)

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma

由 Scheiner, Bernhard, Ulbrich, Gregor, Mandorfer, Mattias, Reiberger, Thomas, Müller, Christian, Waneck, Fredrik, Trauner, Michael, Kölblinger, Claus, Ferlitsch, Arnulf, Sieghart, Wolfgang, Peck-Radosavljevic, Markus, Pinter, Matthias
發表在 United European Gastroenterol J (2019)